Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Pfizer Ltd.
NSE: PFIZER
|
BSE: 500680
|
ISIN: INE182A01018
|
Industry: Pharmaceuticals
|
Mid-range Performer
3847.4000
-17.00
(
-0.44
%)
NSE
Nov 13, 2026
15:31 PM
26.81% Fall from 52W High
Volume:
12,669
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Pfizer Ltd.
26 Feb 2021
3847.40
-0.44%
Pfizer Covid-19 vaccine reduces transmission after one dose: UK study
Business Standard
The study and its results have yet to be independently peer-reviewed by other scientists
Pfizer Ltd. has an
average target
of 5307.50 from 2 brokers.
Astra, Sputnik vaccines face hurdles if Covid shots become annual affair
Business Standard |
26 Feb 2021
8 more
US regulators relax Pfizer COVID-19 vaccine shipping regulations
Business Today |
26 Feb 2021
US loosens Pfizer vaccine shipping regulations
Moneycontrol |
26 Feb 2021
To ease distribution US loosens Pfizer Covid vaccine shipping regulations
Business Standard |
26 Feb 2021
Pfizer-BioNTech testing booster of their Covid-19 vaccine in new trial
Business Standard |
25 Feb 2021
Pfizer studying effects of 3rd vaccine dose against new Covid variants
Business Standard |
25 Feb 2021
Pfizer vaccine shows 94% efficacy in real-world study in Israel
Business Today |
25 Feb 2021
In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world
Moneycontrol |
25 Feb 2021
Pfizer Covid-19 vaccine works well in big 'real world' test, prevents death
Business Standard |
25 Feb 2021
More from Pfizer Ltd.
Recommended
Pre Monday: New opportunities as markets rise, and some tears
The Baseline |
14 Nov 2026, 12:00PM
Not all revenue beats are equal: inside Q2’s biggest surprises
The Baseline |
13 Nov 2026
Earnings Call Transcript - Pfizer
|
04 Feb 2020